Literature DB >> 20735300

Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.

Parinda Srinarong1, Sander Kouwen, Marinella R Visser, Wouter L J Hinrichs, Henderik W Frijlink.   

Abstract

The objective of this study was to compare the dissolution behavior of tablets prepared from solid dispersions with and without drug-carrier interactions. Diazepam and nifedipine were used as model drugs. Two types of carriers were used; polyvinylpyrrolidone (PVP K12, K30 and K60) and saccharides (inulin 1.8 kDa, 4 kDa and 6.5 kDa). Solid dispersions with various drug loads were prepared by lyophilization. It was found that the drug solubility in aqueous PVP solutions was significantly increased indicating the presence of drug-carrier interaction while the drug solubility was not affected by the saccharides indicating absence of drug-carrier interaction. X-ray powder diffraction and modulated differential scanning calorimetry revealed that all solid dispersions were fully amorphous. Dissolution behavior of solid dispersion tablets based on either the PVPs or saccharides was governed by both dissolution of the carrier and drug load. It was shown that a fast drug dissolution of solid dispersions with a high drug load could be obtained with carrier that showed interaction with the drug.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735300     DOI: 10.3109/10837450903286529

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  In vitro and in vivo evaluation of fast-dissolving tablets containing solid dispersion of lamotrigine.

Authors:  Arti Mohan; Rohit Gundamaraju
Journal:  Int J Pharm Investig       Date:  2015 Jan-Mar

2.  In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.

Authors:  Abdulmalik Alqurshi; K L Andrew Chan; Paul G Royall
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

3.  Exploring the molecular reorientations in amorphous rosuvastatin calcium.

Authors:  N M Belozerova; P Bilski; M Jarek; J Jenczyk; S E Kichanov; D P Kozlenko; J Mielcarek; A Pajzderska; J Wąsicki
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.